338
Views
17
CrossRef citations to date
0
Altmetric
Drug Profiles

The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD

&
Pages 979-988 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joshua Caballero, Edress H Darsey, Faith Walters & Heidi W Belden. (2017) Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists. Integrated Pharmacy Research and Practice 6, pages 163-171.
Read now
Felipe L Lopez, Terry B Ernest, Catherine Tuleu & Mine Orlu Gul. (2015) Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opinion on Drug Delivery 12:11, pages 1727-1740.
Read now

Articles from other publishers (15)

Ann C. Childress. (2022) Stimulants. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 373-392.
Crossref
Sanika KOLE, Ashwin KUCHEKAR & Dnyanesh LİMAYE. (2021) Advancements in Formulation Approaches to Pediatric Oral Drug Delivery systems. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Kwadwo Amanor Mfoafo, Masoud Omidian, Charise Dallazem Bertol, Yadollah Omidi & Hossein Omidian. (2021) Neonatal and pediatric oral drug delivery: Hopes and hurdles. International Journal of Pharmaceutics 597, pages 120296.
Crossref
Elahe Zarini-Gakiye, Javad Amini, Nima Sanadgol, Gholamhassan Vaezi & Kazem Parivar. (2020) Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials. Current Molecular Pharmacology 13:4, pages 273-294.
Crossref
Sufen Zhang, Lianghui You, Qu Xu, Jiaxin Ou, Di Wu, Xiaojie Yuan, Zhonghui Liu, Qin Hong, Meiling Tong, Lei Yang & Xia Chi. (2020) Distinct long non-coding RNA and mRNA expression profiles in the hippocampus of an attention deficit hyperactivity disorder model in spontaneously hypertensive rats and control wistar Kyoto rats. Brain Research Bulletin 161, pages 177-196.
Crossref
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman & Zheng-Xiong Xi. (2019) Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology 158, pages 107609.
Crossref
Ronald SteingardSarper TaskiranDaniel F. ConnorJohn S. MarkowitzMark A. Stein. (2019) New Formulations of Stimulants: An Update for Clinicians. Journal of Child and Adolescent Psychopharmacology 29:5, pages 324-339.
Crossref
Sharon B. WigalAnn ChildressSally A. BerryHeidi BeldenFaith WaltersPhillip ChappellNancy ShermanJohn OrazemDonna Palumbo. (2017) Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 27:8, pages 690-699.
Crossref
Hao-Jie ZhuKennerly S. PatrickArthur B. StraughnOwen T. ReevesHilary BernsteinJian ShiHeather J. JohnsonJoshua M. KnightAaron T. SmithRobert J. MalcolmJohn S. Markowitz. (2017) Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. Journal of Clinical Psychopharmacology 37:4, pages 419-428.
Crossref
Hyo-Won Kim, Eunjoo Kim, Ji-Hoon Kim, Jangho Park, Geon Ho Bahn, Yeon Jung Lee, Kyungun Jhung & Dongwon Shin. (2017) The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) - Pharmacological Treatment -. Journal of the Korean Academy of Child and Adolescent Psychiatry 28:2, pages 70-83.
Crossref
Samuele Cortese, Giulia D’Acunto, Eric Konofal, Gabriele Masi & Benedetto Vitiello. (2017) New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability. CNS Drugs 31:2, pages 149-160.
Crossref
Sumin Lee, Jae-Won Choi, Kyoung-Min Kim, Jun Won Kim, Sooyeon Kim, Taewoong Kang, Johanna Inhyang Kim, Young Sik Lee, Bongseog Kim, Doug Hyun Han, Jae Hoon Cheong, Soyoung Irene Lee, Gi Jung Hyun & Bung-Nyun Kim. (2016) The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research Center. Journal of the Korean Academy of Child and Adolescent Psychiatry 27:4, pages 236-266.
Crossref
Richat Abbas, Donna Palumbo, Faith Walters, Heidi Belden & Sally A. Berry. (2016) Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet. Clinical Therapeutics 38:5, pages 1151-1157.
Crossref
Duncan A. Scott, Martin Gignac, Risk N. Kronfli, Anthony Ocana & Gunter W. Lorberg. (2016) Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities. Journal of Correctional Health Care 22:1, pages 46-61.
Crossref
Karran A. Phillips, David H. Epstein & Kenzie L. Preston. (2014) Psychostimulant addiction treatment. Neuropharmacology 87, pages 150-160.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.